Friday, 9 September 2016

Cytosar-U




In the US, Cytosar-U (cytarabine systemic) is a member of the drug class antimetabolites and is used to treat Acute Myeloid Leukemia, Acute Nonlymphocytic Leukemia, Chronic Myelogenous Leukemia, Leukemia, Meningeal Leukemia and Non-Hodgkin's Lymphoma.

US matches:

  • Cytosar-U

Ingredient matches for Cytosar-U



Cytarabine

Cytarabine is reported as an ingredient of Cytosar-U in the following countries:


  • Indonesia

  • Malaysia

  • United States

International Drug Name Search

No comments:

Post a Comment